Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    Clobazam (JAN/USAN/INN)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,209Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Assertio Presents Sympazan Study Data at Neurology Meeting
    Assertio Presents Sympazan Study Data at Neurology Meeting

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147667/0/en/Assertio-to-Present-New-Data-from-Real-World-Evidence-Study-of-SYMPAZAN-at-upcoming-150th-Annual-Meeting-of-the-American-Neurological-Association.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    Enforcement Report - Week of January 22, 2025
    Enforcement Report - Week of January 22, 2025

    22 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-22-2025-57502.pdf

    FDA
    22 Jan 2025
    Share Share
    Enforcement Report - Week of January 15, 2025
    Enforcement Report - Week of January 15, 2025

    15 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf

    FDA
    15 Jan 2025
    Share Share
    Enforcement Report - Week of February 28, 2024
    Enforcement Report - Week of February 28, 2024

    28 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf

    FDA
    28 Feb 2024
    Share Share
    Assertio Provides Educational Grant for New LGS Foundation Treatments Kits
    Assertio Provides Educational Grant for New LGS Foundation Treatments Kits

    24 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/24/2652743/0/en/Assertio-Provides-Educational-Grant-for-New-Lennox-Gastaut-Syndrome-LGS-Foundation-Treatments-Kits.html

    GLOBENEWSWIRE
    24 Apr 2023
    Share Share
    Aquestive offloads film formulation seizure drug to Assertio
    Aquestive offloads film formulation seizure drug to Assertio

    31 Oct 2022

    // Nick Paul Taylor FIERCEPHARMA

    https://www.fiercepharma.com/pharma/aquestive-offloads-film-formulation-seizure-drug-assertio-securing-cash-epinephrine-rd

    Nick Paul Taylor FIERCEPHARMA
    31 Oct 2022
    Share Share